Literature DB >> 20855741

In vitro sensitivity and resistance of 46 Leptospira strains isolated from rats in the Philippines to 14 antimicrobial agents.

Antara Chakraborty1, Satoshi Miyahara, Sharon Y A M Villanueva, Nina G Gloriani, Shin-Ichi Yoshida.   

Abstract

The in vitro susceptibilities of 46 Leptospira isolates from rats to 14 antimicrobial agents were tested. All of the strains were found to be sensitive to ampicillin, cefotaxime, ciprofloxacin, norfloxacin, doxycycline, erythromycin, and streptomycin. In contrast, the tested isolates showed resistance to amphotericin B, 5-fluorouracil, fosfomycin, trimethoprim, sulfamethoxazole, neomycin, and vancomycin. These findings will help in selecting effective and ineffective antimicrobials for treatment of leptospirosis and for the development of new selective media, respectively.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20855741      PMCID： PMC2981263          DOI： 10.1128/AAC.00973-10

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  23 in total

1.  Efficacy of combined furazolidone and neomycin in the control of contamination in Leptospira cultures.

Authors:  D M Myers
Journal:  Antimicrob Agents Chemother       Date:  1975-05       Impact factor: 5.191

2.  In vitro susceptibilities of seven Leptospira species to traditional and newer antibiotics.

Authors:  Duane R Hospenthal; Clinton K Murray
Journal:  Antimicrob Agents Chemother       Date:  2003-08       Impact factor: 5.191

3.  In vitro susceptibilities of five Leptospira strains to 16 antimicrobial agents.

Authors:  S Oie; K Hironaga; A Koshiro; H Konishi; Z Yoshii
Journal:  Antimicrob Agents Chemother       Date:  1983-12       Impact factor: 5.191

Review 4.  Leptospirosis. 3. Maintenance, isolation and demonstration of leptospires.

Authors:  L H Turner
Journal:  Trans R Soc Trop Med Hyg       Date:  1970       Impact factor: 2.184

Review 5.  Clinical observation and treatment of leptospirosis.

Authors:  Y Kobayashi
Journal:  J Infect Chemother       Date:  2001-06       Impact factor: 2.211

6.  Trends in Salmonella enteric serovar Typhi in Nairobi, Kenya from 2004 to 2006.

Authors:  Doris Mueni Mengo; Sam Kariuki; Ann Muigai; Gunturu Revathi
Journal:  J Infect Dev Ctries       Date:  2010-06-30       Impact factor: 0.968

7.  Determination of susceptibilities of 26 Leptospira sp. serovars to 24 antimicrobial agents by a broth microdilution technique.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-10       Impact factor: 5.191

8.  Broth microdilution susceptibility testing for Leptospira spp.

Authors:  Clinton K Murray; Duane R Hospenthal
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

9.  Selective isolation of leptospiras from contaminated material by incorporation of neomycin to culture media.

Authors:  D M Myers; V M Varela-Díaz
Journal:  Appl Microbiol       Date:  1973-05

10.  Ceftriaxone compared with sodium penicillin g for treatment of severe leptospirosis.

Authors:  Thanachai Panaphut; Somnuek Domrongkitchaiporn; Asda Vibhagool; Bandit Thinkamrop; Wattanachai Susaengrat
Journal:  Clin Infect Dis       Date:  2003-06-06       Impact factor: 9.079
View more
  9 in total

1.  Efficacy of a New Recrystallized Enrofloxacin Hydrochloride-Dihydrate against Leptospirosis in a Hamster Model.

Authors:  Alma Carrascosa; Lilia Gutierrez; Alejandro De la Peña; Irma E Candanosa; Graciela Tapia; Hector Sumano
Journal:  Antimicrob Agents Chemother       Date:  2017-10-24       Impact factor: 5.191

2.  Prevalence of leptospirosis among patients attending renal and general outpatient clinics in Mulago Hospital, Kampala, Uganda.

Authors:  Rogers Wambi; William Worodria; James Muleme; Siya Aggrey; Lawrence Mugisha
Journal:  Sci Rep       Date:  2022-05-19       Impact factor: 4.996

3.  Antimicrobial Disk Susceptibility Testing of Leptospira spp. Using Leptospira Vanaporn Wuthiekanun (LVW) Agar.

Authors:  Vanaporn Wuthiekanun; Premjit Amornchai; Sayan Langla; Nicholas J White; Nicholas P J Day; Direk Limmathurotsakul; Sharon J Peacock
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

4.  Doxycycline Attenuates Leptospira-Induced IL-1β by Suppressing NLRP3 Inflammasome Priming.

Authors:  Wenlong Zhang; Xufeng Xie; Dianjun Wu; Xuemin Jin; Runxia Liu; Xiaoyu Hu; Yunhe Fu; Zhuang Ding; Naisheng Zhang; Yongguo Cao
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

5.  Reduced susceptibility in leptospiral strains of bovine origin might impair antibiotic therapy.

Authors:  L Correia; A P Loureiro; W Lilenbaum
Journal:  Epidemiol Infect       Date:  2018-09-04       Impact factor: 2.451

6.  Evaluation by polymerase chain reaction assay of persistent shedding of pathogenic leptospires in the urine of dogs with leptospirosis.

Authors:  Katie Hetrick; Kenneth R Harkin; Lalitha Peddireddi; Jamie Henningson
Journal:  J Vet Intern Med       Date:  2021-11-19       Impact factor: 3.333

7.  Risk factors and predictors of severe leptospirosis in New Caledonia.

Authors:  Sarah Tubiana; Marc Mikulski; Jérôme Becam; Flore Lacassin; Patrick Lefèvre; Ann-Claire Gourinat; Cyrille Goarant; Eric D'Ortenzio
Journal:  PLoS Negl Trop Dis       Date:  2013-01-10

8.  Profiling of Leptospira interrogans, L. santarosai, L. meyeri and L. borgpetersenii by SE-AFLP, PFGE and susceptibility testing--a continuous attempt at species and serovar differentiation.

Authors:  Luisa Z Moreno; Fabiana Miraglia; Walter Lilenbaum; José S F Neto; Julio C Freitas; Zenaide M Morais; Rudy A Hartskeerl; Barbara L P da Costa; Silvio A Vasconcellos; Andrea M Moreno
Journal:  Emerg Microbes Infect       Date:  2016-03-09       Impact factor: 7.163

9.  Origin of the Mobile Di-Hydro-Pteroate Synthase Gene Determining Sulfonamide Resistance in Clinical Isolates.

Authors:  Miquel Sánchez-Osuna; Pilar Cortés; Jordi Barbé; Ivan Erill
Journal:  Front Microbiol       Date:  2019-01-10       Impact factor: 5.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.